These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 23928467

  • 21. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ, Darwish AA, Gras J, Wieërs G, Cornet A, Robert A, Mourad M, Malaise J, de Ville de Goyet J, Reding R, Latinne D.
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [Abstract] [Full Text] [Related]

  • 22. Soluble CD30 as a prognostic factor for outcome following renal transplantation.
    Platt RE, Wu KS, Poole K, Newstead CG, Clark B.
    J Clin Pathol; 2009 Jul; 62(7):662-3. PubMed ID: 19561239
    [Abstract] [Full Text] [Related]

  • 23. High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection?
    Altermann W, Schlaf G, Rothhoff A, Seliger B.
    Nephrol Dial Transplant; 2007 Oct; 22(10):2795-9. PubMed ID: 17616534
    [Abstract] [Full Text] [Related]

  • 24. [Evaluation of immune status of kidney transplant recipients by combined HLA-G5 and sCD30].
    JIN ZK, TIAN PX, XUE WJ, DING XM, PAN XM, DING CG, JIA LN, GE GQ, HAO JJ.
    Zhonghua Yi Xue Za Zhi; 2010 Sep 28; 90(36):2528-31. PubMed ID: 21092456
    [Abstract] [Full Text] [Related]

  • 25. Anti-HLA class II antibodies and chronic allograft nephropathy.
    Gerbase-DeLima M, Campos EF, Tedesco-Silva H, Machado PG, Franco M, Medina-Pestana JO.
    Clin Transpl; 2006 Sep 28; ():201-5. PubMed ID: 18365378
    [Abstract] [Full Text] [Related]

  • 26. Predicting renal graft failure by sCD30 levels and de novo HLA antibodies at 1year post-transplantation.
    Wang D, Wu G, Chen J, Yu Z, Wu W, Yang S, Tan J.
    Transpl Immunol; 2012 Jun 28; 26(4):235-9. PubMed ID: 22446727
    [Abstract] [Full Text] [Related]

  • 27. CD30, a marker to detect the high-risk kidney transplant recipients.
    Spiridon C, Nikaein A, Lerman M, Hunt J, Dickerman R, Mack M.
    Clin Transplant; 2008 Jun 28; 22(6):765-9. PubMed ID: 19040559
    [Abstract] [Full Text] [Related]

  • 28. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, Legendre C, Taupin JL, Duong Van-Huyen JP, Loupy A, Lefaucheur C.
    Kidney Int; 2017 Sep 28; 92(3):729-742. PubMed ID: 28554738
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of pre transplant T-cell activation status by soluble CD 30 determination.
    Abbas K, Muzaffar R, Zafar MN, Mubarak M, Naqvi SA, Rizvi SA.
    J Pak Med Assoc; 2009 Apr 28; 59(4):212-5. PubMed ID: 19402280
    [Abstract] [Full Text] [Related]

  • 30. High pretransplantation soluble CD30 levels: impact in renal transplantation.
    Giannoli C, Bonnet MC, Perrat G, Houillon A, Reydet S, Pouteil-Noble C, Villar E, Lefrançois N, Morelon E, Dubois V.
    Transplant Proc; 2007 Oct 28; 39(8):2574-5. PubMed ID: 17954178
    [Abstract] [Full Text] [Related]

  • 31. Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome.
    Ypsilantis E, Key T, Bradley JA, Morgan CH, Tsui S, Parameshwar J, Taylor CJ.
    J Heart Lung Transplant; 2009 Nov 28; 28(11):1206-10. PubMed ID: 19782609
    [Abstract] [Full Text] [Related]

  • 32. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D, Wu GJ, Wu WZ, Yang SL, Chen JH, Wang H, Lin WH, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2007 Jun 28; 17(4):278-82. PubMed ID: 17493531
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D, Wu WZ, Chen JH, Yang SL, Wang QH, Zeng ZX, Tan JM.
    Transpl Immunol; 2010 Feb 28; 22(3-4):115-20. PubMed ID: 20036333
    [Abstract] [Full Text] [Related]

  • 35. sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil.
    Weimer R, Süsal C, Yildiz S, Streller S, Pelzl S, Staak A, Renner F, Dietrich H, Daniel V, Feuring E, Kamali-Ernst S, Ernst W, Padberg W, Opelz G.
    Transplant Proc; 2005 May 28; 37(4):1776-8. PubMed ID: 15919463
    [Abstract] [Full Text] [Related]

  • 36. sCD30, interleukin-1beta-converting enzyme and anti-Annexin V autoantibodies concentrations in heart transplant recipients.
    Zeglen S, Zakliczyński M, Nozyński J, Rogala B, Zembala M.
    Transpl Immunol; 2006 Nov 28; 16(3-4):227-31. PubMed ID: 17138058
    [Abstract] [Full Text] [Related]

  • 37. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar 28; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 38. High soluble CD30 levels and associated anti-HLA antibodies in patients with failed renal allografts.
    Karahan GE, Caliskan Y, Ozdilli K, Kekik C, Bakkaloglu H, Caliskan B, Turkmen A, Sever MS, Oguz FS.
    Int J Artif Organs; 2017 Jan 13; 39(11):547-552. PubMed ID: 28058698
    [Abstract] [Full Text] [Related]

  • 39. Soluble CD30 concentrations in ESRD patients with and without panel reactive HLA antibodies.
    Vaidya S, Partlow D, Barnes T, Thomas P, Gugliuzza K.
    Clin Transplant; 2006 Jan 13; 20(4):461-4. PubMed ID: 16842522
    [Abstract] [Full Text] [Related]

  • 40. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection?
    Azarpira N, Aghdaie MH, Malekpour Z.
    Saudi J Kidney Dis Transpl; 2010 Jan 13; 21(1):31-6. PubMed ID: 20061689
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.